Microproteins have the potential to improve our understanding of all hallmarks of cancer. Moreover, they an expand the set of druggable targets. Our research aims to establish a set of cancer-associated microproteins that could serve as therapeutic targets. This will be accomplished through functional genomic screens for microproteins that regulate cancer cell phenotypes and a biochemical screen for microprotein interactions with key cancer-signaling proteins.